在良性前列腺增生症的食补充剂中评估β-固醇水平:对治疗有效性的影响
Buț Mădălina-Georgiana1,2, Silvia Imre3, Camil Vari4
1Department of Medical Chemistry and Biochemistry, Faculty of Medicine in English, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, Târgu Mureș, ROU.
Cureus
|May 17, 2024
概括
良性前列腺增生症 (BPH) 的食补充剂往往缺乏足够的β-固醇 (SIT). 质量控制至关重要,以确保这些补充剂提供有效的BPH症状缓解.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学是指药理学,即药理学是指药理学.
- 分析化学 分析化学
背景情况:
- 良性前列腺增生症 (BPH) 由于尿路症状,显著影响老年男性的生活质量.
- 对BPH的药理疗法可能会导致性功能障碍,导致植物性食补充剂 (DS) 的使用增加.
- 对于BPH的DS的疗效可能会受到调节不良和活性化合物度变化的损害,例如β-固醇 (SIT).
研究的目的:
- 量化β-固醇 (SIT) 度在商用BPH的DS中.
- 评估DS中SIT度是否足以在推剂量下获得治疗效益.
- 为了将标记的SIT内容与DS中的实际量化量进行比较.
主要方法:
- 开发一个HPLC-UV方法来量化自由和结合SIT.
- 该方法涉及直接肥和酸化.
- 分析各种DS产品中的SIT度,并与标签声明进行比较.
主要成果:
- 在所有分析的DS中检测到β-固醇 (SIT).
- 在不同的DS产品中观察到SIT含量的显著变化.
- 只有一个产品含有足够的SIT度,可能有利于BPH症状.
结论:
- 在DS中不一致的SIT内容凸显了对标准化摘录的需求.
- 强有力的质量控制措施对于确保BPH基于SIT的DS的有效性和安全性至关重要.
- 需要进一步的研究来建立标准化剂量,并评估长期的疗效和安全性.
相关概念视频
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
757
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
757
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
766
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
766


